Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s106399
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2016
Authors
Publisher
Informa UK Limited